BRIEF—Tetris Pharma partners with Apodi for flagship product launch in the UK

Privately-held UK-based Tetris Pharma has signed a service agreement with Apodi to support the promotion of its lead product in the UK.

Apodi is a UK contract sales organization.

Tetris Pharma will use Apodi’s Endeavour Team, a highly-skilled Omnichannel KAM team with experience in primary and secondary care.

The team will provide UK national coverage in the next few months leveraging Apodi’s Omnichannel expertise to establish a foundation for Tetris Pharma’s commercial activity in the UK.

Tetris Pharma is working with expert development, manufacturing and distribution partners in the UK and mainland Europe, initially to bring to market its lead product to treat severe episodes of hypoglycemia for people with diabetes.